Literature DB >> 22798438

Moyamoya disease presented as a case of hemiplegic migraine.

M R Siddiqui1, S U Khan, M A Hoque, K M Rahman, M B A Mondol, Q D Mohammad.   

Abstract

Moyamoya disease is a rare cerebral vasculopathy characterised by progressive narrowing of the major intracranial vessels and development of collateral vessels. Clinically, it presents with cerebral ischaemic or haemorrhagic events, with eventual severe morbidity and mortality. A 10-year-old girl presented with episodic vascular headache and transient left sided hemiparesis, which persisted for a few hours and was clinically labelled as sporadic hemiplegic migraine according to International Headache Society criteria. We investigated all possible causes of unusual headache. Cerebral digital subtraction angiogram was carried out and moyamoya disease was finally diagnosed.

Entities:  

Mesh:

Year:  2010        PMID: 22798438      PMCID: PMC3029035          DOI: 10.1136/bcr.02.2010.2764

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Moyamoya disease in the midwestern United States.

Authors:  N M Wetjen; P C Garell; N V Stence; C M Loftus
Journal:  Neurosurg Focus       Date:  1998-11-15       Impact factor: 4.047

2.  Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy.

Authors:  S Verret; J C Steele
Journal:  Pediatrics       Date:  1971-04       Impact factor: 7.124

3.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

4.  Hemiplegic migraine and moyamoya disease.

Authors:  A L Bernstein
Journal:  Am J Dis Child       Date:  1993-07

5.  Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.

Authors:  T Yamauchi; M Tada; K Houkin; T Tanaka; Y Nakamura; S Kuroda; H Abe; T Inoue; K Ikezaki; T Matsushima; M Fukui
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

6.  Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.

Authors:  N Khan; B Schuknecht; E Boltshauser; A Capone; A Buck; H G Imhof; Y Yonekawa
Journal:  Acta Neurochir (Wien)       Date:  2003-12-04       Impact factor: 2.216

7.  Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan.

Authors:  Satoshi Kuroda; Nobuo Hashimoto; Takashi Yoshimoto; Yoshinobu Iwasaki
Journal:  Stroke       Date:  2007-03-29       Impact factor: 7.914

8.  Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease.

Authors:  S A Hosain; J T Hughes; S L Forem; J Wisoff; I Fish
Journal:  J Child Neurol       Date:  1994-10       Impact factor: 1.987

9.  Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.

Authors:  Shinichi Kuriyama; Yasuko Kusaka; Miki Fujimura; Kenji Wakai; Akiko Tamakoshi; Shuji Hashimoto; Ichiro Tsuji; Yutaka Inaba; Takashi Yoshimoto
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  Posterior circulation in moyamoya disease: angiographic study.

Authors:  I Yamada; Y Himeno; S Suzuki; Y Matsushima
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

View more
  1 in total

Review 1.  The Migraine-Stroke Connection.

Authors:  Mi Ji Lee; Chungbin Lee; Chin-Sang Chung
Journal:  J Stroke       Date:  2016-05-31       Impact factor: 6.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.